Latest clinical trials News | Page 35

Research recommendations to prevent limb amputation
Pre-clinical data for Kazia Therapeutics’ EVT801 published in cancer journal
AstraZeneca showcases strength of haematology portfolio and pipeline across multiple hard-to-treat conditions
Therapeutic Products Bill introduced
Why autistic children are more likely to have gut problems
Mater Research Showcase shines light on 2022 achievements
Analysis of impact of antivirals
Positive media coverage of cannabis studies regardless of therapeutic effect
COVID nasal sprays may one day prevent and treat infection
World’s first algae-based local anaesthetic another step closer to reality
We’re told to ‘eat a rainbow’ of fruit and vegetables
CSL secures US approval for breakthrough one-time haemophilia gene therapy
Honourable Anna Bligh AC joins forces with Griffith University to fight malaria
MND research goes global
Schizophrenia research led by UNSW academics receives $3m in NSW Health grants
Hope in Sight Community Forum 2022
U.S. Food and Drug Administration approves CSL’s HEMGENIX , first gene therapy for hemophilia B
IND approval from US FDA for theranostic SARBombesin trial in prostate cancer
Phase 2 trial of ChulaCov19 BNA159 mRNA Vaccine to start in Australia
AusBiotech Policy Forum: Biotech leaders head to Parliament
NSW new $4 million to improve schizophrenia treatment
WHO to identify pathogens that could cause future outbreaks and pandemics
Pancreas models may save life
Australian-first project to map people living with Huntington’s Disease
Jennie Mackenzie donates 20 million to Charles Perkins Centre
Telix acquires US radiochemistry business Optimal Tracers
ATAGI recommendations on use of Pfizer bivalent Covid vaccine
Long serving CSIRO Chief Executive Dr Larry Marshall to conclude third and final term June 2023
Budget support for biomanufacturing in Queensland
Women who have suffered health complications associated with Essure contraceptive device urged to register for Slater and Gordon
Australian doctors lead world-first cancer trial to treat rare leukaemia
AstraZeneca expands global footprint in rare disease with availability of first Alexion rare disease therapy for patients
Balloon labour induction safer for babies, Melbourne researchers find
Year-to-date and Q3 2022 results
Researchers find Strep A’s Achilles heel with potential vaccine to prevent rheumatic heart disease
Protein insights may boost lung cancer treatment
Clinical trial to assess potential needle-free vaccination for Covid
Australia has potential to reduce lung cancer deaths, major international clinical trials show
Farxiga improved symptom burden and health-related quality of life
Nurses and midwives plead case for more research funding
AstraZeneca presents data at ASN Kidney Week 2022 reinforcing urgent need for early screening of chronic kidney disease and benefits
Beyfortus approved in EU for prevention of RSV lower respiratory tract disease in infants
Human trials to begin on SA-made universal pneumococcal vaccine
UQ company starts revolution in chronic pain management
Gene technologies are giving hope to patients with deadly rare diseases
Gene technologies are giving hope to patients with deadliest rare diseases
Crucial program changing lives of regional patients
AstraZeneca funds R&D Postdoctoral Challenge finalists